Ventyx Biosciences, Inc.·4

Nov 25, 9:07 PM ET

Mohan Raju 4

4 · Ventyx Biosciences, Inc. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-22
Mohan Raju
DirectorCEO AND PRESIDENT
Transactions
  • Purchase

    Common Stock

    2024-11-22$1.83/sh+238,248$434,9461,913,276 total
  • Purchase

    Common Stock

    2024-11-25$2.01/sh+261,752$524,9442,175,028 total
Footnotes (2)
  • [F1]Represents the weighted average share price of an aggregate total of 238,248 shares purchased in the price range of $1.74 to $1.91. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Represents the weighted average share price of an aggregate total of 261,752 shares purchased in the price range of $1.915 to $2.0978. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    form4-11262024_021129.xmlPrimary